WARSAW, Ind., July 16, 2012 /PRNewswire/ -- Zimmer Holdings, Inc. (NYSE: ZMH; SIX: ZMH), a global leader in musculoskeletal care, today announced that Christopher B. Begley, former Chairman and Chief Executive Officer of Hospira, Inc., has been appointed to its Board of Directors.
"With more than 25 years of experience managing and directing leading healthcare and life science companies, as well as extensive board representation in a variety of consumer-facing industries, Chris Begley brings a unique perspective to Zimmer's Board," said John L. McGoldrick, Chairman of the Board of Directors. "We are delighted Chris has agreed to join the Board and look forward to his contributions to Zimmer's strategic vision and direction."
Mr. Begley served as Executive Chairman of Hospira from May 2007 until January 2012 and as Hospira's Chief Executive Officer from April 2004, when Hospira was spun off from Abbott Laboratories, to March 2011. He served in various positions with Abbott between 1986 and 2004, most recently as Senior Vice President of Abbott's Hospital Products division. Mr. Begley serves as non-executive chairman of the board of Hillshire Brands Company and as a director of DeVry Inc. He previously served as a director of Sara Lee Corporation, the Advanced Medical Technology Association (AdvaMed) and the National Center for Healthcare Leadership (NCHL).
Mr. Begley earned a bachelor's degree from Western Illinois University and a master's degree in business administration from Northern Illinois University.
About the Company
Founded in 1927 and headquartered in Warsaw, Indiana, Zimmer designs, develops, manufactures and markets orthopaedic reconstructive, spinal and trauma devices, dental implants, and related surgical products. Zimmer has operations in more than 25 countries around the world and sells products in more than 100 countries. Zimmer's 2011 sales were appr
|SOURCE Zimmer Holdings, Inc.|
Copyright©2012 PR Newswire.
All rights reserved